Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes

This publication has 17 references indexed in Scilit:

• A 96‐Week Comparison of Lopinavir‐Ritonavir Combination Therapy Followed by Lopinavir‐Ritonavir Monotherapy versus Efavirenz Combination Therapy
  The Journal of Infectious Diseases, 2008
• The level of persistent HIV viremia does not increase after successful simplification of maintenance therapy to lopinavir/ritonavir alone
  AIDS, 2006
• A Pilot Study of Switch to Lopinavir/Ritonavir (LPV/r) Monotherapy from Nonnucleoside Reverse Transcriptase Inhibitor–Based Therapy
  HIV Research & Clinical Practice, 2006
• Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy After Sustained Virologic Suppression
  JAMA, 2006
• Three- vs Four-Drug Antiretroviral Regimens for the Initial Treatment of HIV-1 InfectionA Randomized Controlled Trial
  JAMA, 2006
• Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis
  Journal of Clinical Microbiology, 2005
• Long-Term Efficacy and Safety of Atazanavir With Stavudine and Lamivudine in Patients Previously Treated With Nelfinavir or Atazanavir
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
• Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
  New England Journal of Medicine, 2004
• Ritonavir boosted indinavir treatment as a simplified maintenance ‘mono'-therapy for HIV infection
  AIDS, 2004
• Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
  AIDS Care, 2000